scholarly journals Recomendação de vitamina k para pacientes em uso de anticoagulante oral / Vitamin k recommendation for patients using oral anticoagulant

2021 ◽  
Vol 7 (11) ◽  
pp. 108578-108596
Author(s):  
Emmanuella Oliveira Caúla Garzone ◽  
Tathiany Jéssica Ferreira ◽  
Luciene de Oliveira ◽  
Rita Simone Lopes Moreira
2015 ◽  
Vol 54 (3) ◽  
pp. 184-193 ◽  
Author(s):  
Anita Jug Došler ◽  
Petra Petročnik ◽  
Ana Polona Mivšek ◽  
Teja Zakšek ◽  
Metka Skubic

Abstract Introduction. The aim of the study was to explore two aspects of neonatal prophylaxis: the application of the vitamin K injection to the newborns and the prophylaxis against chlamydial and gonococcal eye infections, comparing Slovenian and Croatian practices. Methods. A causal non-experimental method of quantitative empirical approach was used. The data was collected by means of predesigned questionnaires. The questionnaires were sent to 14 Slovenian and 32 Croatian birth hospitals. The data wasanalysed with descriptive statistics and the Kullback test. Results. Vitamin K is applied to all newborns in 9 (out of 14) Slovene and 22 (out of 32) Croatian birth hospitals that returned the questionnaire. The prophylaxis against chlamydial gonococcal eye infections is applied to all newborns in 9 Slovene and 16 Croatian birth hospitals that offered answers to the questionnaire. The majority of Slovene and Croatian birth hospitals perform these procedures in the first hour after birth. The majority of Slovene birth hospitals still apply vitamin K in the gluteal muscle, whereas the majority of Croatian birth hospitals usually use the thigh as an injection site. In Slovenia, 1 % Targesin is used for the prophylaxis against chlamydial and gonococcal eye infections, whereas in Croatia the prevailing medicine is Erythromycin. Conclusions. The possibility of oral vitamin K application should be offered to parents, and pain management in practice should be discussed. The form of written informed consent could be offered to parents. Health professionals should provide intimacy and exclude routine procedures in the first couple of hours after birth. However, more research is needed as delayed administration might be related to lower efficacy and, as a consequence of that, the safety of newborns is questionable.


PEDIATRICS ◽  
1994 ◽  
Vol 94 (1) ◽  
pp. 132-132
Author(s):  
Bruce Arroll ◽  
J. Thompson

We are writing to express our concerns about the recommendations of the Vitamin K Ad Hoc Task Force (Pediatrics 1993;91:1001-1002). Although we agree with some of their arguments, we feel that recommendation 3, which gives guidelines for using oral vitamin K, is both premature and unwarranted given the problems with the Golding et al1 paper. The design has numerous points for concern as does the interpretation because vitamin K in the United Kingdom contains three vehicles; any one of which could be the causative agent if indeed injected vitamin K does cause cancer.


Sign in / Sign up

Export Citation Format

Share Document